Search clinical trials for: High Risk Multiple Myeloma
Total 43026 results
-
The First Affiliated Hospital of Soochow UniversityNot yet recruitingMultiple Myeloma | Newly Diagnosed | MRD | High Risk
-
Shanghai Changzheng HospitalCARsgen Therapeutics Co., Ltd.Not yet recruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Janssen Research & Development, LLCNot yet recruitingLymphoma | Multiple Myeloma | Hodgkin Lymphoma | Myelofibrosis | Non Hodgkin Lymphoma | Chronic Myeloid Leukemia | Hematologic Malignancy | Aplastic Anemia | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML) | Bone Marrow Transplant Rejection | Acute Lymphoblastic Leukemia (ALL), Adult
-
Affiliated Hospital of Nantong UniversityRecruiting
-
University of UtahRecruitingSmoldering Multiple MyelomaUnited States
-
M.D. Anderson Cancer CenterPfizerNot yet recruitingMultiple Myeloma | Post-transplant MRD-guided Maintenance Therapy | Pre-transplant PurgingUnited States
-
Stichting European Myeloma NetworkPfizerRecruitingSmoldering Multiple MyelomaNetherlands, France, Italy, Finland, Greece, Norway
-
National Cancer Institute (NCI)Recruiting
-
Wuhan Union Hospital, ChinaRecruitingMultiple Myeloma | Extramedullary Multiple Myeloma | Primary Plasma Cell LeukemiaChina
-
Regeneron PharmaceuticalsNot yet recruitingMonoclonal Gammopathy of Undetermined Significance (MGUS) | Smoldering Multiple Myeloma (SMM)
-
Carl Ola Landgren, MD, PhDJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States
-
Regeneron PharmaceuticalsRecruiting
-
PETHEMA FoundationJanssen PharmaceuticaRecruitingHigh-Risk de Novo Multiple MyelomaSpain
-
Institute of Hematology & Blood Diseases HospitalRecruitingMultiple MyelomaChina
-
Oslo University HospitalTargovax ASARecruitingMultiple Myeloma | Smoldering Multiple MyelomaNorway
-
M.D. Anderson Cancer CenterSanofiRecruitingMultiple MyelomaUnited States
-
Second Affiliated Hospital, School of Medicine,...Shaoxing People's Hospital; Shaoxing Second Hospital; Huizhou Municipal Central... and other collaboratorsRecruiting
-
Institute of Hematology & Blood Diseases HospitalCellular Biomedicine Group Ltd.Recruiting
-
University of RochesterKaryopharm Therapeutics IncRecruitingSmoldering Multiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingPlasma Cell Myeloma | ISS Stage III Plasma Cell MyelomaUnited States
-
Irene Ghobrial, MDJanssen Research & Development, LLCRecruitingMultiple Myeloma | Smoldering Multiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
Xia ZhongjunAntengene CorporationRecruiting
-
Emory UniversityNational Cancer Institute (NCI); GlaxoSmithKlineRecruitingPlasma Cell MyelomaUnited States
-
Nanjing IASO Biotherapeutics Co.,LtdNot yet recruiting
-
M.D. Anderson Cancer CenterRecruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingSmoldering Plasma Cell MyelomaUnited States
-
Shanghai Changzheng HospitalGracell Biotechnology Shanghai Co., Ltd.Recruiting
-
National Cancer Institute (NCI)Janssen Scientific Affairs, LLCRecruiting
-
Cartesian TherapeuticsRecruiting
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI)RecruitingSmoldering Plasma Cell MyelomaUnited States
-
Omar Nadeem, MDJanssen, LPRecruitingMultiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Not yet recruitingPlasma Cell Myeloma | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
CellCentric Ltd.RecruitingAcute Myeloid Leukemia | Multiple Myeloma | Non Hodgkin Lymphoma | Peripheral T Cell Lymphoma | Haematological Malignancy | Higher-risk Myelodysplastic SyndromeUnited Kingdom, United States, France, Sweden, Spain
-
The First Affiliated Hospital of Soochow UniversityRecruiting
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingSmoldering Plasma Cell MyelomaUnited States
-
University Health Network, TorontoRecruitingMelanoma | Lymphoma | Kidney Cancer | Leukemia | Cancer | Breast Cancer | Head and Neck Cancer | Ovarian Cancer | Lynch Syndrome | Lung Cancer | Colon Cancer | Meningioma | BRCA1 Mutation | BRCA2 Mutation | Myeloma | Mutation | Uterine Cancer | Cowden SyndromeCanada
-
Dana-Farber Cancer InstituteStand Up To CancerRecruitingMultiple MyelomaUnited States
-
Sun Yat-sen UniversityRecruitingMyeloma | Newly Diagnosed | High RiskChina
-
CelgeneRecruitingMultiple MyelomaUnited States, France, Germany, Spain, United Kingdom, Italy
-
The First Affiliated Hospital of Soochow UniversityRecruiting
-
Masonic Cancer Center, University of MinnesotaRecruitingLymphoma | Follicular Lymphoma | Acute Myeloid Leukemia | Multiple Myeloma | Myelofibrosis | Juvenile Myelomonocytic Leukemia | Burkitt Lymphoma | Acute Lymphoblastic Leukemia | Lymphoblastic Lymphoma | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Acute Leukemia | Mantle-Cell Lymphoma | Chronic Myelogenous... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingSmoldering Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Recurrent Hodgkin Lymphoma | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Recurrent Non-Hodgkin Lymphoma | Recurrent Acute Lymphoblastic Leukemia | Recurrent Chronic... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Plasma Cell Leukemia | Loss of Chromosome 17p | Autologous Hematopoietic Stem Cell Transplant RecipientUnited States
-
Universitätsklinikum Hamburg-EppendorfActive, not recruiting
-
Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia (AML) | Metastatic Colorectal Cancer (mCRC) | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Relapsed/Refractory Multiple Myeloma (RRMM) | Higher-Risk Myelodysplastic Syndrome (HR-MDS) | Newly Diagnosed Intermediate/High-Risk MDSUnited States, France, Canada, Spain, China
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Light Chain Deposition DiseaseUnited States, Puerto Rico, Ireland
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedMultiple Myeloma | High Risk Smoldering Multiple MyelomaUnited States
-
Janssen Research & Development, LLCActive, not recruitingSmoldering Multiple MyelomaUnited States, Netherlands, Belgium, Canada, Israel, Czechia, Denmark, Japan, Hungary, Turkey, United Kingdom, Spain, Sweden, France, Germany, Italy, Russian Federation, Poland, Mexico, Australia, Brazil, Greece, Argentina, Norway